{{Rsnum
|rsid=8018687
|Gene=ESR2
|Chromosome=14
|position=64227364
|Orientation=plus
|GMAF=0.1662
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ESR2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 1.8 | 12.4 | 85.8
| HCB | 0.0 | 18.4 | 81.6
| JPT | 0.9 | 13.3 | 85.8
| YRI | 21.8 | 53.1 | 25.2
| ASW | 14.3 | 48.2 | 37.5
| CHB | 0.0 | 18.4 | 81.6
| CHD | 0.0 | 22.9 | 77.1
| GIH | 4.0 | 31.7 | 64.4
| LWK | 15.0 | 57.9 | 27.1
| MEX | 0.0 | 13.8 | 86.2
| MKK | 12.8 | 51.9 | 35.3
| TSI | 0.0 | 21.6 | 78.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=19654868
|Title=Genetic polymorphisms of estrogen receptors alpha and beta and the risk of developing prostate cancer
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}